Alzamend Neuro growth metrics data for the quarter ended Jul 2026. These growth metrics cover 24 quarters of results from Oct 2020 through Jul 2026, standardized by Business Quant from the company’s SEC filings.
| Growth Metrics | Oct2020 | Jan2021 | Apr2021 | Jul2021 | Oct2021 | Jan2022 | Apr2022 | Jul2022 | Oct2022 | Jan2023 | Apr2023 | Jul2023 | Oct2023 | Jan2024 | Apr2024 | Jul2024 | Oct2024 | Jan2025 | Apr2025 | Jul2025 | Oct2025 | Jan2026 | Apr2026 | Jul2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth Ratios | ||||||||||||||||||||||||
| Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y) | -774.62% | -706.53% | -17,955.54% | -1,070.86% | -286.39% | -1,576.86% | 1.01% | 3.02% | 22.26% | 59.35% | 90.89% | 95.83% | 42.27% | 51.94% | -285.63% | -1,256.63% | 3.03% | -219.90% | -755.35% | -38.75% | ||||
| Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y) | 39.62% | -197.29% | -280.23% | -153.47% | 22.05% | -20.14% | -48.52% | 29.67% | 18.13% | 24.22% | 14.50% | -44.31% | 7.74% | |||||||||||
| Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y) | 34.07% | -71.20% | -142.88% | -251.58% | -54.90% | |||||||||||||||||||
| Interest Coverage Ratio (QoQ)Interest Cover (QoQ) | -32.40% | 30.00% | -4,001.40% | 69.20% | 56.31% | -203.80% | -142.11% | 69.83% | 64.97% | -58.83% | 45.73% | 86.19% | -384.75% | -32.23% | -335.48% | 51.40% | 65.35% | -336.25% | -1,064.38% | 92.12% | ||||
| Return on Assets [ROA] Growth (1y)ROA Growth (1y) | -3611.00 | -5797.00 | -9083.00 | -11460.00 | -26187.00 | -72852.00 | -124110.00 | -120042.00 | -28281.00 | 66,458.00 | 131,226.00 | 130,395.00 | 52,835.00 | 7,218.00 | -6214.00 | -18380.00 | -5707.00 | |||||||
| Return on Assets [ROA] Growth (3y)ROA Growth (3y) | -58080.00 | -12191.00 | -1967.00 | -1107.00 | -1634.00 | 824.00 | 902.00 | -8027.00 | 18,846.00 | |||||||||||||||
| Return on Assets [ROA] Growth (5y)ROA Growth (5y) | -10952.00 | |||||||||||||||||||||||
| Return on Assets [ROA] (QoQ)ROA (QoQ) | 849.00 | -1908.00 | -1940.00 | -612.00 | -1337.00 | -5195.00 | -4317.00 | -15338.00 | -48001.00 | -56453.00 | -250.00 | 76,423.00 | 46,738.00 | 8,315.00 | -1080.00 | -1138.00 | 1,121.00 | -5117.00 | -13246.00 | 11,535.00 | ||||
| Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) | -3501.00 | -7187.00 | -15197.00 | -24265.00 | ||||||||||||||||||||
| Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) | 1,279.00 | -1638.00 | -2572.00 | -569.00 | -2408.00 | -9647.00 | -11641.00 | |||||||||||||||||
| Return on Equity [ROE] Growth (1y)ROE Growth (1y) | 132,330.00 | -3642.00 | -6728.00 | -13290.00 | -23645.00 | -94147.00 | 33,944.00 | -9686.00 | -47649.00 | -14430.00 | ||||||||||||||
| Return on Equity [ROE] Growth (3y)ROE Growth (3y) | -40166.00 | -3936.00 | -2402.00 | -2744.00 | 506.00 | -332.00 | -26406.00 | 76,974.00 | ||||||||||||||||
| Return on Equity [ROE] Growth (5y)ROE Growth (5y) | 82,279.00 | -20816.00 | ||||||||||||||||||||||
| Return on Equity [ROE] (QoQ)ROE (QoQ) | 1,139.00 | -1917.00 | -1969.00 | -895.00 | -1947.00 | -8478.00 | -12324.00 | -71398.00 | 34,314.00 | -436.00 | -1237.00 | 1,303.00 | -9316.00 | -38399.00 | 31,982.00 |
Pull Alzamend Neuro's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=ALZN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "ALZN", "statement": "Growth", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=ALZN&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();